Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

Novel antiinflammatory protein available for licensing

Jan. 22, 1997

AutoImmune updates clinical program for oral RA product

Jan. 17, 1997

Genelabs completes first pivotal trial on SLE Rx

Jan. 16, 1997

Chiroscience investigates MMP/TNF inhibitors

Jan. 16, 1997

Searle describes antiinflammatory oxazoles

Jan. 15, 1997

New COX-2 inhibitor series reported by Merck Frosst

Jan. 15, 1997

Chiroscience reports new peptidyl compounds for treating degenerative diseases

Jan. 14, 1997

Phase I ConXn data reported

Jan. 10, 1997

Chondrex license agreement option exercised

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...